Related Experiment Video
Updated: Oct 15, 2025

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.7K
Elderly-Onset Multiple System Atrophy with Lewy Body Pathology: A Case Report
Kazuhiro Fukushima1, Akinori Nakamura1, Yo-Ichi Takei1
1Department of Neurology, National Hospital Organization, Matsumoto Medical Center, Matsumoto, Japan.
Case Reports in Neurology
|October 27, 2021
Summary
This case study highlights a rare overlap of Multiple System Atrophy (MSA) and Parkinson's disease (PD) pathology. Autopsy revealed synucleinopathy in autonomic ganglia, potentially explaining sudden death in this MSA patient.
Area of Science:
- Neurology
- Pathology
Background:
- Multiple System Atrophy (MSA) is a rare, sporadic, and fatal neurodegenerative disorder characterized by autonomic dysfunction, parkinsonism, and cerebellar ataxia.
- Parkinson's disease (PD) is a progressive neurodegenerative disorder primarily affecting dopamine-producing neurons in the substantia nigra.
Observation:
- An 81-year-old woman presented with progressive dysarthria and gait disturbance, later developing orthostatic hypotension, sleep apnea, tremor, and rigidity, consistent with MSA.
- Despite dysphagia and choking, she declined artificial feeding or tracheostomy.
- She died suddenly at age 91, with autopsy revealing neuropathological features of both MSA and PD.
Findings:
- Autopsy confirmed co-existing MSA and PD pathology.
- Peripheral autonomic ganglia showed pre- and postganglionic synucleinopathy, a potential factor in sudden death.
- The patient survived 10 years post-onset, longer than expected given poor prognostic factors like old age, early autonomic dysfunction, falls, and co-existing PD pathology.
Implications:
- This case underscores the complex interplay between MSA and PD pathologies.
- Peripheral autonomic synucleinopathy may contribute to sudden mortality in MSA.
- Multidisciplinary care and preserved cognition may facilitate longer survival in MSA patients, even with complicating factors.
Related Concept Videos
Parkinson's Disease: Overview
832
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
832
Lysosomal Hydrolases
4.0K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K
Alzheimer's Disease: Overview
744
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
744
Neural Regulation
40.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.5K
Parkinson's Disease: Treatment
441
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
441

